BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 28278702)

  • 41. Mantle cell lymphoma displays a homogenous methylation profile: a comparative analysis with chronic lymphocytic leukemia.
    Halldórsdóttir AM; Kanduri M; Marincevic M; Mansouri L; Isaksson A; Göransson H; Axelsson T; Agarwal P; Jernberg-Wiklund H; Stamatopoulos K; Sander B; Ehrencrona H; Rosenquist R
    Am J Hematol; 2012 Apr; 87(4):361-7. PubMed ID: 22374828
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Genome-wide methylation analyses identify a subset of mantle cell lymphoma with a high number of methylated CpGs and aggressive clinicopathological features.
    Enjuanes A; Albero R; Clot G; Navarro A; Beà S; Pinyol M; Martín-Subero JI; Klapper W; Staudt LM; Jaffe ES; Rimsza L; Braziel RM; Delabie J; Cook JR; Tubbs RR; Gascoyne R; Connors JM; Weisenburger DD; Greiner TC; Chan WC; López-Guillermo A; Rosenwald A; Ott G; Campo E; Jares P
    Int J Cancer; 2013 Dec; 133(12):2852-63. PubMed ID: 23754783
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Toll-Like Receptor 1/2 and 5 Ligands Enhance the Expression of Cyclin D1 and D3 and Induce Proliferation in Mantle Cell Lymphoma.
    Mastorci K; Muraro E; Pasini E; Furlan C; Sigalotti L; Cinco M; Dolcetti R; Fratta E
    PLoS One; 2016; 11(4):e0153823. PubMed ID: 27123851
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Novel cross talk of Kruppel-like factor 4 and beta-catenin regulates normal intestinal homeostasis and tumor repression.
    Zhang W; Chen X; Kato Y; Evans PM; Yuan S; Yang J; Rychahou PG; Yang VW; He X; Evers BM; Liu C
    Mol Cell Biol; 2006 Mar; 26(6):2055-64. PubMed ID: 16507986
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Haploinsufficiency of Krüppel-like factor 4 promotes adenomatous polyposis coli dependent intestinal tumorigenesis.
    Ghaleb AM; McConnell BB; Nandan MO; Katz JP; Kaestner KH; Yang VW
    Cancer Res; 2007 Aug; 67(15):7147-54. PubMed ID: 17671182
    [TBL] [Abstract][Full Text] [Related]  

  • 46. PRMT5 activates lipid metabolic reprogramming via MYC contributing to the growth and survival of mantle cell lymphoma.
    Liang JH; Wang WT; Wang R; Gao R; Du KX; Duan ZW; Zhang XY; Li Y; Wu JZ; Yin H; Shen HR; Wang L; Li JY; Guo JR; Xu W
    Cancer Lett; 2024 Jun; 591():216877. PubMed ID: 38615930
    [TBL] [Abstract][Full Text] [Related]  

  • 47. KLF4 Mediates the Effect of 5-ASA on the β-Catenin Pathway in Colon Cancer Cells.
    Parenti S; Montorsi L; Fantini S; Mammoli F; Gemelli C; Atene CG; Losi L; Frassineti C; Calabretta B; Tagliafico E; Ferrari S; Zanocco-Marani T; Grande A
    Cancer Prev Res (Phila); 2018 Aug; 11(8):503-510. PubMed ID: 29794245
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Development and characterization of a Mantle Cell Lymphoma Cell Bank in the American Type Culture Collection.
    Fogli LK; Williams ME; Connors JM; Reid Y; Brown K; O'Connor OA
    Leuk Lymphoma; 2015 Jul; 56(7):2114-22. PubMed ID: 25315077
    [TBL] [Abstract][Full Text] [Related]  

  • 49. LncRNA MALAT1 promotes development of mantle cell lymphoma by associating with EZH2.
    Wang X; Sehgal L; Jain N; Khashab T; Mathur R; Samaniego F
    J Transl Med; 2016 Dec; 14(1):346. PubMed ID: 27998273
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Expression of KLF4 is a predictive marker for survival in pediatric Burkitt lymphoma.
    Valencia-Hipόlito A; Hernández-Atenógenes M; Vega GG; Maldonado-Valenzuela A; Ramon G; Mayani H; Peña Alonso Y; Martinez-Maza O; Méndez-Tenorio A; Huerta-Yepez S; Bonavida B; Vega MI
    Leuk Lymphoma; 2014 Aug; 55(8):1806-14. PubMed ID: 24067139
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identification of V-ATPase as a molecular sensor of SOX11-levels and potential therapeutic target for mantle cell lymphoma.
    Emruli VK; Olsson R; Ek F; Ek S
    BMC Cancer; 2016 Jul; 16():493. PubMed ID: 27430213
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Epigenetic alterations of Krüppel-like factor 4 and its tumor suppressor function in renal cell carcinoma.
    Li H; Wang J; Xiao W; Xia D; Lang B; Yu G; Guo X; Guan W; Wang Z; Hu Z; Liu J; Ye Z; Xu H
    Carcinogenesis; 2013 Oct; 34(10):2262-70. PubMed ID: 23722653
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Combined administration of rituximab and on 013105 induces apoptosis in mantle cell lymphoma cells and reduces tumor burden in a mouse model of mantle cell lymphoma.
    Prasad A; Shrivastava A; Papadopoulos E; Kuzontkoski PM; Reddy MV; Gillum AM; Kumar R; Reddy EP; Groopman JE
    Clin Cancer Res; 2013 Jan; 19(1):85-95. PubMed ID: 23124440
    [TBL] [Abstract][Full Text] [Related]  

  • 54. KLF4 downregulates hTERT expression and telomerase activity to inhibit lung carcinoma growth.
    Hu W; Jia Y; Xiao X; Lv K; Chen Y; Wang L; Luo X; Liu T; Li W; Li Y; Zhang C; Yu Z; Huang W; Sun B; Deng WG
    Oncotarget; 2016 Aug; 7(33):52870-52887. PubMed ID: 27153563
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mantle cell lymphoma-variant Richter syndrome: Detailed molecular-cytogenetic and backtracking analysis reveals slow evolution of a pre-MCL clone in parallel with CLL over several years.
    Klener P; Fronkova E; Berkova A; Jaksa R; Lhotska H; Forsterova K; Soukup J; Kulvait V; Vargova J; Fiser K; Prukova D; Alam M; Calvin Lenyeletse Maswabi B; Michalova K; Zemanova Z; Jancuskova T; Pekova S; Trneny M
    Int J Cancer; 2016 Nov; 139(10):2252-60. PubMed ID: 27407063
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Epigenetic repression of Krüppel-like factor 4 through Dnmt1 contributes to EMT in renal fibrosis.
    Xiao X; Tang W; Yuan Q; Peng L; Yu P
    Int J Mol Med; 2015 Jun; 35(6):1596-602. PubMed ID: 25892014
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Janus-faced roles of Krüppel-like factor 4 in oral squamous cell carcinoma cells.
    Li W; Liu M; Su Y; Zhou X; Liu Y; Zhang X
    Oncotarget; 2015 Dec; 6(42):44480-94. PubMed ID: 26517087
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Downregulated Krüppel‑like factor 4 expression is associated with the aggressiveness of prostate cancer.
    Zhang N; Su P; Li X; Xi J; Li X; Xu L
    Oncol Rep; 2019 Mar; 41(3):1789-1796. PubMed ID: 30747213
    [TBL] [Abstract][Full Text] [Related]  

  • 59. miR-223 is repressed and correlates with inferior clinical features in mantle cell lymphoma through targeting SOX11.
    Zhou K; Feng X; Wang Y; Liu Y; Tian L; Zuo W; Yi S; Wei X; Song Y; Qiu L
    Exp Hematol; 2018 Feb; 58():27-34.e1. PubMed ID: 29158064
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Biological and clinical significance of GSK-3beta in mantle cell lymphoma--an immunohistochemical study.
    Chung R; Peters AC; Armanious H; Anand M; Gelebart P; Lai R
    Int J Clin Exp Pathol; 2010 Jan; 3(3):244-53. PubMed ID: 20224723
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.